SP Elixir (OPC) Private Limited

Leuben (Bortezomib) 100 mg injection is a medication used to treat certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor that works by blocking the proteasome, a complex in the cell responsible for breaking down proteins. By inhibiting the proteasome, Bortezomib causes the buildup of damaged proteins within cancer cells, which leads to their death.

Uses:

• Multiple Myeloma: Leuben is often used in the treatment of multiple myeloma, a cancer of plasma cells in the bone marrow.
• Mantle Cell Lymphoma (MCL): It is also used to treat mantle cell lymphoma, a rare type of non-Hodgkin lymphoma.

How It Works:

Leuben (Bortezomib) inhibits the proteasome's function, which is essential for breaking down proteins within cells. By blocking this action, it disrupts cell function and leads to the accumulation of damaged proteins, ultimately causing cancer cells to die. This action is particularly effective in cancer cells that are rapidly dividing.

Dosage:

The dosage of Leuben (Bortezomib) will depend on the specific type of cancer, your overall health, and how your body responds to treatment. It is typically administered by injection into a vein (IV) or under the skin (subcutaneous).

• For multiple myeloma, Bortezomib is often given in cycles, typically twice a week for two weeks, followed by a one-week rest period.
• For mantle cell lymphoma, it may also be given in cycles with rest periods between doses.

Your healthcare provider will determine the exact dosing schedule.

Side Effects:

Some common side effects of Leuben (Bortezomib) may include:

• Nausea and vomiting
• Diarrhea or constipation
• Fatigue
• Low blood cell counts (e.g., low red or white blood cells, low platelets)
• Peripheral neuropathy (tingling or numbness in hands and feet)
• Fever
• Weakness
• Liver function changes

More serious side effects include heart problems, lung issues, and severe infections. Your doctor will monitor you closely for these and other potential issues during treatment.

Administration:

• Leuben (Bortezomib) is typically administered by a healthcare professional in a hospital or clinic setting, either via IV infusion or subcutaneously.
• It is important to follow the prescribed dosing schedule and attend regular follow-up appointments to monitor for side effects or signs of infection or organ toxicity.

Important Considerations:

• Drug Interactions: Let your doctor know if you are taking any other medications, as Bortezomib may interact with certain drugs, including anticoagulants and other chemotherapy medications.
• Pregnancy and Breastfeeding: Bortezomib is not recommended during pregnancy, as it may harm the fetus. It should be avoided while breastfeeding as well.
• Infection Risk: Since Bortezomib can lower your white blood cell count, you may be more vulnerable to infections, so it's essential to avoid exposure to illness during treatment.

If you are receiving Leuben (Bortezomib), it is critical to follow your healthcare provider's instructions closely and report any unusual side effects immediately. Regular blood tests and monitoring are essential during treatment to ensure that any complications are caught early.

Bendmustine 100mg inj